Financial Gravity Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
EC
BI
DM
PM
SBH
FC
Financial Gravity Asset Management's LKFT Position: Q1 2024 in Review
Financial Gravity Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 12 shares — an estimated $446 sold.
Financial Gravity Asset Management first reported a position in LKFT in Q1 2018 and held it in 21 quarters. The position peaked at $344K in Q1 2019. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.
- Financial Gravity Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Financial Gravity Asset Management sold 12 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $446.
- Financial Gravity Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 21 quarters.
- Financial Gravity Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $344K in Q1 2019.
- 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.
Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.